header-logo header-logo

A class apart

07 January 2010 / Roger Birch
Issue: 7399 / Categories: Features , Regulatory
printer mail-detail

Roger Birch on the misperceptions in defining medicinal products

There are a number of serious misperceptions upon which products are caught by the definition of what is a medicinal product. This is a serious matter and leads to confusion among members of the public and those who sell such substances which they believe are not caught by the Misuse of Drugs Act 1971, Sch 2.

The Medicines Act 1968 (MA 1968) seems to be forgotten when a particular product is being offered for sale and/or placed on the market.

Let us take the substance BZP as an example.

On the 20 March 2007 a press release was issued by MHRA. They stated that BZP (PEP) pills are dangerous and illegal The press release then states that “any other pills containing Piperazine…or its salts or derivatives would be classified as unlicensed…”.

There then appears in the Mail Online an article dated the 20 March 2007 where the MHRA state that “people are being bamboozled into thinking that BZP is safe because they are being billed

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Weightmans—Emma Eccles & Mark Woodall

Weightmans—Emma Eccles & Mark Woodall

Firm bolsters Manchester insurance practice with double partner appointment

Gilson Gray—Linda Pope

Gilson Gray—Linda Pope

Partner joins family law team inLondon

Jackson Lees Group—five promotions

Jackson Lees Group—five promotions

Private client division announces five new partners

NEWS
The landmark Supreme Court’s decision in Johnson v FirstRand Bank Ltd—along with Rukhadze v Recovery Partners—redefine fiduciary duties in commercial fraud. Writing in NLJ this week, Mary Young of Kingsley Napley analyses the implications of the rulings
Barristers Ben Keith of 5 St Andrew’s Hill and Rhys Davies of Temple Garden Chambers use the arrest of Simon Leviev—the so-called Tinder Swindler—to explore the realities of Interpol red notices, in this week's NLJ
Mazur v Charles Russell Speechlys [2025] has upended assumptions about who may conduct litigation, warn Kevin Latham and Fraser Barnstaple of Kings Chambers in this week's NLJ. But is it as catastrophic as first feared?
Lord Sales has been appointed to become the Deputy President of the Supreme Court after Lord Hodge retires at the end of the year
Limited liability partnerships (LLPs) are reportedly in the firing line in Chancellor Rachel Reeves upcoming Autumn budget
back-to-top-scroll